Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line

Figure 1

In vitro cumulative release (%) study of LY2835219 from HACNP/LY or CNP/LY in physiological pH (pH 7.4) media at 37°C by dialysis membrane assay.